According to Anebulo Pharmaceuticals latest financial reports the cash on hand of ANEB is $11.25M, an decrease of -22.69% to 2022. At the end of 2022 company had $14.55M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $11.25M | -22.69% |
2022 | $14.55M | -27.21% |
2021 | $19.99M | 560.69% |
2020 | $3.02M | - |